home / stock / saga / saga short
Short Information | Sagaliam Acquisition Corp. (NASDAQ:SAGA)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,337 |
Total Actual Volume | 79,043 |
Short Trends | |
---|---|
Cover Days | 14 |
Short Days | 3 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 67 |
Average Short Percentage | 25.18% |
Is there a SAGA Short Squeeze or Breakout about to happen?
See the SAGA Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
03-07-2024 | $10.88 | $10.88 | $10.88 | $10.88 | 986 | 2 | 0.2% |
03-06-2024 | $0 | $10.88 | $0 | $0 | 151 | 53 | 35.1% |
03-01-2024 | $10.9 | $10.9 | $10.9 | $10.9 | 153 | 37 | 24.18% |
02-28-2024 | $0 | $10.9 | $0 | $0 | 68 | 30 | 44.12% |
02-23-2024 | $0 | $10.88 | $0 | $0 | 53 | 48 | 90.57% |
02-16-2024 | $10.87 | $10.9 | $10.9 | $10.87 | 2,132 | 123 | 5.77% |
02-05-2024 | $10.97 | $10.905 | $10.97 | $10.9 | 69,409 | 100 | 0.14% |
02-02-2024 | $0 | $11.05 | $0 | $0 | 10 | 7 | 70% |
01-26-2024 | $0 | $11.03 | $0 | $0 | 65 | 16 | 24.62% |
01-19-2024 | $10.9601 | $10.9601 | $10.9601 | $10.9601 | 112 | 7 | 6.25% |
01-16-2024 | $10.95 | $10.97 | $10.99 | $10.94 | 4,447 | 805 | 18.1% |
01-11-2024 | $0 | $10.91 | $0 | $0 | 26 | 25 | 96.15% |
01-08-2024 | $10.9101 | $10.91 | $10.9101 | $10.91 | 407 | 2 | 0.49% |
01-05-2024 | $0 | $10.92 | $0 | $0 | 79 | 7 | 8.86% |
01-04-2024 | $0 | $10.92 | $0 | $0 | 33 | 8 | 24.24% |
01-02-2024 | $0 | $10.92 | $0 | $0 | 16 | 6 | 37.5% |
12-22-2023 | $10.92 | $10.92 | $10.92 | $10.92 | 209 | 6 | 2.87% |
12-21-2023 | $10.92 | $10.92 | $10.92 | $10.92 | 103 | 3 | 2.91% |
12-20-2023 | $0 | $10.945 | $0 | $0 | 103 | 1 | 0.97% |
12-18-2023 | $10.945 | $10.945 | $10.945 | $10.945 | 481 | 51 | 10.6% |
News, Short Squeeze, Breakout and More Instantly...
Sagaliam Acquisition Corp. Company Name:
SAGA Stock Symbol:
NASDAQ Market:
BAYTOWN, TX / ACCESSWIRE / May 1, 2024 / Sagaliam Acquisition Corp ("SAGA", the "Company") (NASDAQ:SAGA) announced today that Virogentics, Inc., a wholly owned subsidiary of SAGA ("VIRO"), and the Bulgarian product development team, headed by Dr. Lachezar Ivanov and Harry Zhabilov, CSO, have dev...
NEW YORK, NY / ACCESSWIRE / April 26, 2024 / Sagaliam Acquisition Corp. ("SAGAU", "SAGA", SAGAR") (the " Company ") announced that Sagaliam entered into a Novation Agreement with Enzolytics, Inc. (OTC PINK:ENZC), Biogenysis, Inc. (BGEN), and Virogentics, Inc. (VIRO) (together the "Parties"). ...
New York, NY, March 07, 2024 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, SAGAR”) (the “ Company ”) received a Nasdaq Hearing Withdrawal letter (“ Notice ”) from the Listing Qualifications staff of ...